The in-vitro activity of sparfloxacin was compared with that of pefloxacin, ofloxacin, ciprofloxacin, imipenem, ceftazidime, gentamicin and amikacin against 275 multiresistant nosocomial clinical isolates. They consisted of Pseudomonas aeruginosa (37), Enterobacter cloacae (42), Acinetobacter anitratus (60), Klebsiella pneumoniae (37) and Staphylococcus sp (99). Minimum inhibitory concentrations (MIC90) and geometric mean MICs for sparfloxacin were as follows (mg/l): P. aeruginosa 128-23.7, E. cloacae 1-0.13, A. anitratus 2-0.14, K. pneumoniae 1-0.08, MRSA 16-0.98, MSSA 0.12-0.03, MRSE 0.25-0.12 and MSSE 0.12-0.05. It is concluded that sparfloxacin was the most potent agent against staphylococci and A. anitratus including strains resistant to the other quinolones while ciprofloxacin was the most potent agent against P. aeruginosa, E. cloacae and K. pneumoniae.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/1120009x.1992.11739131 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis and Characterization of Two Sparfloxacin Crystalline Salts: Enhancing Solubility and In Vitro Antibacterial Activity of Sparfloxacin.
Pharmaceutics
November 2024
School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
: To improve the solubility and permeability of Sparfloxacin (SPX) and enhance its antimicrobial activity in vitro, two unreported pharmaceutical crystalline salts were synthesized and characterized in this paper. One is a hydrated crystal of Sparfloxacin with Pimelic acid (PIA), another is a hydrated crystal of Sparfloxacin with Azelaic acid (AZA), namely, SPX-PIA-HO (2CHFNO·CHO·2HO) and SPX-AZA-HO (4CHFNO·2CHO·5HO). : The structure and purity of two crystalline salts were analyzed using solid-state characterization methods such as single-crystal X-ray diffraction, powder X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, and infrared spectroscopy.
View Article and Find Full Text PDFTherapeutic potential of Chromolaena odorata, Vernonia amygdalina, and Cymbopogon citratus against pathogenic Bacteria.
Sci Rep
January 2025
Departmment of Microbiology and Immunology, Kampala International University, Ishaka, Uganda.
Antimicrobial resistance poses a global public health threat, compelling the search for alternative treatments, especially in resource-limited settings. The increasing ineffectiveness of traditional antibiotics has intensified the need to explore medicinal plants as viable therapeutic options. This study sought to compare the efficacy of certain medicinal plants used in Owerri, Nigeria, for treating pathogenic bacteria against traditional commercial antibiotics.
View Article and Find Full Text PDFBloodstream Infection Combined with Thoracic Infection Caused by : A Case Report and Review of the Literature.
Infect Drug Resist
December 2024
Department of Laboratory Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, People's Republic of China.
Objective: is usually found in urogenital tract infections and is associated with several extra-genitourinary infections, including septic arthritis, bacteremia, and meningitis. Here, we report a rare case of induced bloodstream infection with thoracic inflammation in a surgical patient.
Methods: A 56-year-old male who underwent surgery for multiple pelvic and rib fractures developed fever, pleural effusion, and wound exudation despite receiving prophylactic anti-infection treatment with cefotiam.
An AIE active luminogen derived using 2-hydroxy-1-naphthaldehyde and 3-hydroxy-2-naphthohydrazide for the detection of sparfloxacin and azithromycin.
Anal Methods
January 2025
Department of Chemistry, Sardar Vallabhbhai National Institute of Technology, Surat-395007, Gujarat, India.
Herein, an aggregation-induced emission (AIE) luminogen (AIEgen) NANH was developed by condensing equimolar amounts of 2-hydroxy-1-naphthaldehyde and 3-hydroxy-2-naphthohydrazide. The AIE behaviour of NANH was explored in a mixed DMSO-HO (HEPES buffer, pH 7.4, 10 mM) medium.
View Article and Find Full Text PDFMolecular insights into the aspartate protease Plasmepsin II activity inhibition by fluoroquinolones: A pathway to antimalarial drug development.
Int J Biol Macromol
January 2025
UM-DAE Centre for Excellence in Basic Sciences, University of Mumbai, Vidyanagri Campus, Kalina, Mumbai 400098, India. Electronic address:
Article Synopsis
- Plasmepsin II (PlmII) is an important enzyme in Plasmodium falciparum that helps in breaking down hemoglobin, making it a key target for new antimalarial drugs.
- Research successfully produced and activated Pro-plasmepsin II, confirming its functionality through various enzyme studies, and identified that norfloxacin and ciprofloxacin can effectively inhibit this enzyme, unlike sparfloxacin.
- The study suggests repurposing these fluoroquinolone antibiotics for malaria treatment, highlighting their mechanism of action at the enzyme’s active site, which could lead to new therapeutic options against malaria.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!